CIK 0001420565
- Non-accelerated filer
- Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 134196017
- Phone
- +1 737-802-1989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-05 | Platt Jon B. 10% owner | Conversion | +90,218 | 90,318 | ||
| 2017-07-05 | Platt Jon B. 10% owner | Conversion · Series C-2 Preferred Stock | −211,930 | 0 | ||
| 2017-07-05 | Platt Jon B. 10% owner | Conversion · Series D Preferred Stock | −127,158 | 0 | ||
| 2017-07-05 | Platt Jon B. 10% owner | Conversion · Series E Preferred Stock | −298,500 | 0 | ||
| 2017-07-05 | Platt Jon B. 10% owner | Conversion · Series E-1 Preferred Stock | −258,912 | 0 | ||
| 2017-07-05 | ROCHE HOLDING LTD 10% owner | Conversion | +579,093 | 582,963 | ||
| 2017-07-05 | ROCHE HOLDING LTD 10% owner | Purchase | +119,400 | $15.00 | $1.8M | 702,363 |
| 2017-07-05 | ROCHE HOLDING LTD 10% owner | Conversion · Series D Preferred Stock | −3,390,885 | 0 | ||
| 2017-07-05 | ROCHE HOLDING LTD 10% owner | Conversion · Series E-2 Preferred Stock | −735,775 | 0 | ||
| 2017-07-05 | ROCHE HOLDING LTD 10% owner | Conversion · Series E-3 Preferred Stock | −638,194 | 0 | ||
| 2017-07-05 | ROCHE HOLDING LTD 10% owner | Conversion · Series F Preferred Stock | −989,594 | 0 | ||
| 2017-07-05 | CVF, LLC 10% owner | Conversion | +536,180 | 536,180 | ||
| 2017-07-05 | CVF, LLC 10% owner | Purchase | +180,000 | $15.00 | $2.7M | 716,180 |
| 2017-07-05 | CVF, LLC 10% owner | Conversion · Series E-3 Preferred Stock | −4,411,765 | 0 | ||
| 2017-07-05 | CVF, LLC 10% owner | Conversion · Series F Preferred Stock | −916,262 | 0 | ||
| 2017-07-05 | Kapnick Scott Director | Conversion | +285,438 | 295,076 | ||
| 2017-07-05 | Kapnick Scott Director | Purchase | +159,307 | $15.00 | $2.4M | 454,383 |
| 2017-07-05 | Kapnick Scott Director | Purchase | +66,666 | $15.00 | $1000K | 521,049 |
| 2017-07-05 | Kapnick Scott Director | Conversion · Series D Preferred Stock | −106,856 | 0 | ||
| 2017-07-05 | Kapnick Scott Director | Conversion · Series D-1 Preferred Stock | −363,636 | 0 |
Page 15 of 16 · 320 trades